Cord Blood America, Inc. (CBAI.OB) reports that the family of Matthew Schissler, CEO, has loaned the Company $223,500, through an arrangement involving a third party, to reduce debt.
“Putting money into the Company provides it the short term working capital it needs, something that doesn’t occur if this discretionary money were spent instead on purchasing stock on the open market,” Mr. Schissler said. “This investment gives us the opportunity to focus on the long term growth.”
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children.
Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.
Let us hear your thoughts below: